Focal Segmental Glomerulosclerosis
📧 Sign up to get email alerts when something new happens for Focal Segmental Glomerulosclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects [Phase 4]
Phase 4 trial investigating dApagliflozin for reducing albuminuria and normalizing hemodynamic function in focal segmental glomerulosclerosi…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) [Phase 2]
This report covers results from a Phase II repeat-dose study of losmapimod in patients with focal segmental glomerulosclerosis to assess its…
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients
This clinical trial update describes a prospective controlled study evaluating serum suPAR levels in CsA-treated patients with focal segment…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis [NA]
A clinical trial evaluating tacrolimus for treated refractory focal segmental glomerulosclerosis has been terminated. The update notes the t…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial [Phase 2]
Phase II clinical trial update for novel therapies targeting resistant focal segmental glomerulosclerosis (FSGS) under FONTII, with results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Permeability Factor in Focal Segmental Glomerulosclerosis [Phase 1, Phase 2]
Phase 1 and Phase 2 studies evaluated a permeability factor in focal segmental glomerulosclerosis. The trial results were posted in 2016 and…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis) [Phase 1]
This clinical trial update describes an early-phase study of allogeneic adipose-derived mesenchymal stem cell transplantation for idiopathic…
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor [Phase 1]
A Phase 1 clinical trial evaluating oral galactose for the FSGS permeability factor has been terminated. The study, sponsored by Northwell H…
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) [Phase 2]
Phase 2 clinical trial update indicating completion of a study evaluating Fresolimumab in patients with steroid-resistant primary focal segm…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Regional Citrate Anticoagulation in Plasma Exchange Treatment [NA]
This record notes completion of a clinical trial evaluating regional citrate anticoagulation during plasma exchange for treatment of Focal s…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome [NA]
A completed clinical trial evaluated oral galactose in children with steroid-resistant nephrotic syndrome, including focal segmental glomeru…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH [Phase 4]
This Phase 4 trial update reports results from using adrenocorticotropic hormone (ACTH) to treat idiopathic focal segmental glomeruloscleros…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease [Phase 4]
Phase 4 trial evaluating aldosterone breakthrough during Diovan, Tekturna, and combination therapy in proteinuric kidney disease was termina…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS [Phase 1]
The document reports completion of a Phase 1 safety study of GC1008 (fresolimumab) in patients with treatment-resistant idiopathic focal seg…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental [Phase 3]
Phase 3 trial update showing completion status for mycophenolate mofetil in membranous nephropathy and focal segmental glomerulosclerosis.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis
Clinical trial investigating cardiomyopathy in steroid-resistant nephrotic syndrome associated with focal segmental glomerulosclerosis has b…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) [Phase 3]
Phase 3 clinical trial update for rituximab in multirelapsing minimal change disease or focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) [Phase 2]
A Phase 2 trial evaluating pirfenidone for focal segmental glomerulosclerosis (kidney fibrosis) has completed and posted results in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT) [Phase 3]
The Phase 3 FSGS-CT trial for focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Steroid Treatment for Kidney Disease [Phase 3]
A Phase 3 clinical trial update evaluating steroid treatment for kidney diseases (nephrotic syndrome and focal segmental glomerulosclerosis)…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis [NA]
A completed clinical trial evaluated prednisone in combination with Tripterygium wilfordii for adults with idiopathic focal segmental glomer…
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis [NA]
This clinical trial update describes evaluating a combination of low-dose prednisone, mycophenolate mofetil, and tacrolimus for focal segmen…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Sirolimus for Focal Segmental Glomerulosclerosis [Phase 2]
A Phase 2 trial evaluating sirolimus for focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis [Phase 2]
Phase 2 clinical trial evaluating once-a-month steroid treatment for focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2007-10-22Clinical Trial Update: Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) [Phase 1]
Phase 1 pilot studies are exploring novel therapies for resistant focal segmental glomerulosclerosis (FSGS); the trials have completed.